Cargando…
A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study
BACKGROUND: H1-antihistamines are recommended as the first-line symptomatic treatment of allergic rhinitis. The objective of this study was to evaluate the effects of rupatadine (RUP) versus desloratadine (DES) in subjects with seasonal allergic rhinitis (SAR). METHOD: To assess the efficacy and saf...
Autores principales: | Lukat, KF, Rivas, P, Roger, A, Kowalski, ML, Botzen, U, Wessel, F, Sanquer, F, Agache, I, Izquierdo, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582315/ https://www.ncbi.nlm.nih.gov/pubmed/23459334 http://dx.doi.org/10.2147/JAA.S39496 |
Ejemplares similares
-
Route to Prolonged
Residence Time at the Histamine
H(1) Receptor: Growing from Desloratadine to Rupatadine
por: Bosma, Reggie, et al.
Publicado: (2019) -
Allergic rhinoconjunctivitis
por: Miraglia del Giudice, Michele, et al.
Publicado: (2020) -
Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020) -
Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
por: Mullol, Joaquim, et al.
Publicado: (2019) -
Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study
por: Tang, Rui, et al.
Publicado: (2022)